Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ebru Özan Sanhal

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Tuberkuloz Ve Toraks|November 12, 2019
Incidental pulmonary nodule frequency in TurkeyNalan Ogan, Ayşe Baha, Ebru Özan Sanhal, et al.
Biomolecules & Biomedicine|June 23, 2026
Breast cancer response to neoadjuvant chemotherapy: Pre-treatment NLR, PLR, LMR, and SII do not predict pathological complete response or residual cancer burdenİsmail Zİhnİ, Mehmet Zafer Sabuncuoğlu, Burcu Zİhnİ, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Tuberkuloz Ve Toraks|November 12, 2019
Incidental pulmonary nodule frequency in TurkeyNalan Ogan, Ayşe Baha, Ebru Özan Sanhal, et al.
Biomolecules & Biomedicine|June 23, 2026
Breast cancer response to neoadjuvant chemotherapy: Pre-treatment NLR, PLR, LMR, and SII do not predict pathological complete response or residual cancer burdenİsmail Zİhnİ, Mehmet Zafer Sabuncuoğlu, Burcu Zİhnİ, et al.
Pageof 1